NCT00859196View on ClinicalTrials.gov

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Wound HealingCell ProliferationGene Expression
Interventions
DRUG

Dexpanthenol (BAY81-2996)

Test product and the respective placebo will be applied to previously wounded test areas and the surrounding skin (approx. 3 cm2). After a certain time the second skin biopsy will be taken from the treated test areas. The skin biopsies will be analysed via micro array.

DRUG

Placebo

Test product and the respective placebo will be applied to previously wounded test areas and the surrounding skin (approx. 3 cm2). After a certain time the second skin biopsy will be taken from the treated test areas. The skin biopsies will be analysed via micro array.

Trial Locations (1)

22869

Hamburg

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00859196 - Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries | Biotech Hunter | Biotech Hunter